317 related articles for article (PubMed ID: 10408003)
1. [Statins in secondary prevention of coronary heart disease].
Sandhofer F
Wien Med Wochenschr; 1999; 149(5-6):125-8. PubMed ID: 10408003
[TBL] [Abstract][Full Text] [Related]
2. [Statins in primary prevention of coronary heart disease].
Paulweber B
Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
[TBL] [Abstract][Full Text] [Related]
3. [Lowering cholesterol 1998. Cholesterol synthesis inhibitors compared].
Kostner KM; Kostner GM
Wien Klin Wochenschr; 1998 Oct; 110(18):625-30. PubMed ID: 9816634
[TBL] [Abstract][Full Text] [Related]
4. [Prevention of coronary heart disease with statins. Which patients profit?].
Adam O; Forth W
MMW Fortschr Med; 2003 Jun; 145(25):37-40. PubMed ID: 12891851
[TBL] [Abstract][Full Text] [Related]
5. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
Hague W; Forder P; Simes J; Hunt D; Tonkin A;
Am Heart J; 2003 Apr; 145(4):643-51. PubMed ID: 12679760
[TBL] [Abstract][Full Text] [Related]
6. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.
Daskalopoulou SS; Mikhailidis DP
Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035
[TBL] [Abstract][Full Text] [Related]
7. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
[TBL] [Abstract][Full Text] [Related]
8. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
[TBL] [Abstract][Full Text] [Related]
9. [Effect of cholesterol reducing therapy with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on secondary prevention after myocardial infarction in Japanese patients].
Tachibana E; Watanabe I; Nagao K; Kanmatsuse K
J Cardiol; 2000 Apr; 35(4):277-85. PubMed ID: 10791271
[TBL] [Abstract][Full Text] [Related]
10. Statins for stroke prevention: disappointment and hope.
Amarenco P; Tonkin AM
Circulation; 2004 Jun; 109(23 Suppl 1):III44-9. PubMed ID: 15198966
[TBL] [Abstract][Full Text] [Related]
11. [Statins--attaining goal values--with reference to recent studies].
Toplak H; Schallmoser K; DeCampo A
Wien Med Wochenschr; 1999; 149(5-6):144-5. PubMed ID: 10408006
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of Atorvastatin-induced very low-density lipoprotein cholesterol levels in Patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study).
LaRosa JC; Grundy SM; Kastelein JJ; Kostis JB; Greten H;
Am J Cardiol; 2007 Sep; 100(5):747-52. PubMed ID: 17719314
[TBL] [Abstract][Full Text] [Related]
13. Statins for primary and secondary prevention of coronary heart disease. A scientific review.
Carneiro AV; Costa J; Borges M
Rev Port Cardiol; 2004 Jan; 23(1):95-122. PubMed ID: 15058150
[TBL] [Abstract][Full Text] [Related]
14. Statins, super-statins and cholesterol absorption inhibitors.
Brousseau ME
IDrugs; 2003 May; 6(5):458-63. PubMed ID: 12789600
[TBL] [Abstract][Full Text] [Related]
15. [Prevention of coronary heart diseases in clinical practice. Comment on the recommendations of the Second Joint Task Force of European Societies for Prevention of Coronary Disease].
Klein W; Maurer G; Patsch JR; Sandhofer F; Silberbauer K
Wien Med Wochenschr; 1999; 149(5-6):111-8. PubMed ID: 10408001
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of atorvastatin in treating high risk patients to reach low density lipoprotein-cholesterol goals: the Treat to Target (TTT-Israel) Study.
Leibovitz E; Harats D; Gavish D
Isr Med Assoc J; 2002 Jun; 4(6):407-10. PubMed ID: 12073409
[TBL] [Abstract][Full Text] [Related]
17. [The role of cholesterol-lowering drugs in prevention of coronary heart disease].
Skałuba Z; Undas R
Przegl Lek; 1998; 55(7-8):382-7. PubMed ID: 10021881
[TBL] [Abstract][Full Text] [Related]
18. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
Strandberg TE; Feely J; Sigurdsson EL;
Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
[TBL] [Abstract][Full Text] [Related]
19. [Hyperlipidemia: decreasing lipid values and effects of statins].
Mathes P
Z Kardiol; 2002; 91 Suppl 2():25-9. PubMed ID: 12436762
[No Abstract] [Full Text] [Related]
20. Cholesterol: precursor to many lipid disorders.
Jones PH
Am J Manag Care; 2001 Aug; 7(9 Suppl):S289-98. PubMed ID: 11517815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
